Search

everythinglearnresearchcommunity

for

Search:↓

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Nanoparticles offer significant benefits over traditional chemotherapy for cancer treatment.

Surgery for high-risk prostate cancer is challenging but doesn't lead to more complications, and additional treatment is often needed.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

The new nanoparticles could improve melanoma treatment by working better than current options.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

Ultrasound and nanocarriers could make breast cancer treatment safer and more effective.

A new system was created to classify skin changes in cancer patients based on their treatment.

A man with a rare adrenal cancer showed unusual symptoms and died four months after diagnosis.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

More research is needed to confirm initial findings on hair loss patterns from chemotherapy.

Self-care strategies, especially diet and lifestyle changes, help manage cancer treatment symptoms.

Guilu Erxian Glue may help reduce chemotherapy side effects like weight loss and heart stress.

Hormone therapy might be a proactive alternative to watchful waiting for early-stage prostate cancer, potentially improving survival without aggressive treatment downsides.

A botanical extract may help manage hair loss from chemotherapy by preventing cell death in hair follicles.

Chemotherapy for prostate, bladder, and testicular cancer patients commonly causes hair loss, fatigue, and decreased appetite.

Topical calcitriol may reduce hair loss from chemotherapy at higher doses.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

A special gel with medicine helps prevent melanoma from coming back after surgery.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

A topical lotion helped manage hair loss from chemotherapy by affecting cell death, inflammation, and collagen, with no side effects.

Scalp cooling therapy helped over 80% of women keep at least half their hair during chemotherapy.

Topical calcitriol is safe for preventing hair loss during chemotherapy.

The formula YH0618 can reduce the harmful side effects of the chemotherapy drug Doxorubicin and protect healthy cells.

A woman's Cushing's syndrome caused by adrenal cancer improved after surgery.

Low-dose oral minoxidil might help with hair loss during chemotherapy, but more research is needed.

Combining Proton Minibeam with FLASH Radiotherapy may improve cancer treatment by reducing side effects and increasing effectiveness.